Lyle J. Arnold serves as Executive at BIOCEPT INC, where they oversee executive responsibilities. Since joining the company, Lyle J. Arnold has executed 4 insider transactions totaling $49.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 31, 2017 involved receiving (via award) 25,000 shares valued at $0.
Lyle J. Arnold currently holds 90,238 shares of BIOCEPT INC (BIOC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lyle J. Arnold has been a net buyer of BIOC stock. They have purchased $49.5K and sold $0 worth of shares.
Lyle J. Arnold's most recent insider trade was on May 31, 2017, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.10 |
| Discretionary |
| Jul 6, 2016 | BIOC | $0 | Award | 50,000 | $N/A | Discretionary |
| Aug 24, 2015 | BIOC | $0 | Option Exercise | 10,714 | $N/A | Discretionary |